Shanshan Dai

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Sanyo (Japan), Jiangsu T-mab BioPharma (China), Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine · ORCID：0000-0001-5124-5882

发表论文 40 篇 · 总被引 1280 次 · h-index 20

代表论文

• GSDMD Mediates LPS-Induced Septic Myocardial Dysfunction by Regulating ROS-dependent NLRP3 Inflammasome Activation (2021 · Frontiers in Cell and Developmental Biology · 被引 85)
• Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage (2022 · Translational research · 被引 70)
• GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis (2022 · Hypertension · 被引 51)
• Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formation (2023 · Basic Research in Cardiology · 被引 50)
• Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury (2022 · Inflammation Research · 被引 40)
• Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD (2023 · Phytomedicine · 被引 36)